1-4 of 4
Michele W. L. Teng
Close
Sort by
Journal Articles

TIGIT immune checkpoint blockade restores CD8 + T-cell immunity against multiple myeloma

Brief Report
Camille Guillerey, Heidi Harjunpää, Nadège Carrié, Sahar Kassem, Tricia Teo, Kim Miles, Sophie Krumeich, Marianne Weulersse, Marine Cuisinier, Kimberley Stannard, Yuan Yu, Simone A. Minnie, Geoffrey R. Hill, William C. Dougall, Hervé Avet-Loiseau, Michele W. L. Teng, Kyohei Nakamura, Ludovic Martinet, Mark J. Smyth
Journal: Blood
Blood (2018) 132 (16): 1689–1694.
https://doi.org/10.1182/blood-2018-01-825265
Published: 2018
Journal Articles

Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8 + T cells that induce GVHD without antileukemic effects

Kate H. Gartlan, Kate A. Markey, Antiopi Varelias, Mark D. Bunting, Motoko Koyama, Rachel D. Kuns, Neil C. Raffelt, Stuart D. Olver, Katie E. Lineburg, Melody Cheong, Bianca E. Teal, Mary Lor, Iain Comerford, Michele W. L. Teng, Mark J. Smyth, James McCluskey, Jamie Rossjohn, Brigitta Stockinger, Glen M. Boyle, Steven W. Lane, Andrew D. Clouston, Shaun R. McColl, Kelli P. A. MacDonald, Geoffrey R. Hill
Journal: Blood
Blood (2015) 126 (13): 1609–1620.
https://doi.org/10.1182/blood-2015-01-622662
Published: 2015
Includes: Supplemental data
Journal Articles

Does IL-17 suppress tumor growth?

Shin Foong Ngiow, Mark J. Smyth, Michele W. L. Teng
Journal: Blood
Blood (2010) 115 (12): 2554–2555.
https://doi.org/10.1182/blood-2009-11-254607
Published: 2010
Journal Articles

Adoptive transfer of gene-engineered CD4 + helper T cells induces potent primary and secondary tumor rejection

Maria Moeller, Nicole M. Haynes, Michael H. Kershaw, Jacob T. Jackson, Michele W. L. Teng, Shayna E. Street, Loretta Cerutti, Stephen M. Jane, Joseph A. Trapani, Mark J. Smyth, Phillip K. Darcy
Journal: Blood
Blood (2005) 106 (9): 2995–3003.
https://doi.org/10.1182/blood-2004-12-4906
Published: 2005